Cheng Kong Shih
Chief Executive Officer at Xuanzhu Biopharmaceutical Co., Ltd.
Profile
Cheng Kong Shih is currently the Vice Chairman, Chief Scientist & General Manager at Xuanzhu Biopharmaceutical Co., Ltd.
He started this position in 2021.
Prior to his current role, he obtained a doctorate degree from The Rockefeller University.
Cheng Kong Shih active positions
| Companies | Position | Start |
|---|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Chief Executive Officer | 01/12/2018 |
Training of Cheng Kong Shih
| The Rockefeller University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Commercial Services |
- Stock Market
- Insiders
- Cheng Kong Shih
